Modeling nanoparticle-alveolar epithelial cell interactions under breathing conditions using captive bubble surfactometry

Langmuir

Volumn 30, Issue 17, 2014, Pages 4924-4932

  Schürch, David ^a,b   Vanhecke, Dimitri ^a   Clift, Martin J D ^a   Raemy, David ^a,b   De Aberasturi, Dorleta Jimenez ^c   Parak, Wolfgang J ^c   Gehr, Peter ^b   Petri Fink, Alke ^a   Rothen Rutishauser, Barbara ^a,d  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CELL CULTURE; MEDICAL NANOTECHNOLOGY; PHASE INTERFACES;

AIR LIQUID INTERFACES; BREATHING CONDITION; CELL CULTURE MODELS; EPITHELIAL BARRIER; EPITHELIAL CELLS; GOLD NANOPARTICLES; STATIC CONDITIONS; SURFACTANT FILMS;

NANOPARTICLES;

NANOPARTICLE; SURFACTANT;

CHEMISTRY; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; HUMAN; LUNG ALVEOLUS;

EPITHELIAL CELLS; HUMANS; NANOPARTICLES; PULMONARY ALVEOLI; SURFACE-ACTIVE AGENTS;

EID: 84899861699     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la500307q     Document Type: Article

References (32)

1. Heyder, J.; Rudolf, G.; Schiller, C.; Stahlhofen, W. Deposition of particles in the human respiratory tract in the size range 0.005-15 μm J. Aerosol Sci. 1986, 17, 811-825
2. Patton, J. S.; Byron, P. R. Inhaling medicines: delivering drugs to the body through the lungs Nat. Rev. Drug Discovery 2007, 6, 67-74
3. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles Environ. Health Perspect. 2005, 113, 823-839
4. Gehr, P.; Schürch, S.; Berthiaume, Y.; Im Hof, V.; Geiser, M. Particle retention in airways by surfactant J. Aerosol Med. 1990, 3, 27-43
5. Ochs, M.; Weibel, E. Functional design of the human lung for gas exchange. Fishman' Pulmonary Diseases and Disorders, 4 th ed.; McGraw-Hill: New York, 2008.
6. Kilburn, K. H. A hypothesis for pulmonary clearance and its implications Am. Rev. Respir. Dis. 1968, 98, 449-63
7. De Jong, W. H.; Borm, P.-J. A. Drug delivery and nanoparticles: Applications and hazards Int. J. Nanomed. 2008, 3, 133-149
8. Mansour, H. M.; Rhee, Y.-S.; Wu, X. Nanomedicine in pulmonary delivery Int. J. Nanomed. 2009, 4, 299-319
9. Rothen-Rutishauser, B.; Kiama, S. G.; Gehr, P. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles Am. J. Respir. Cell Mol. Biol. 2005, 32, 281-289
10. Huh, D.; Matthews, B. D.; Mammoto, A.; Montoya-Zavala, M.; Hsin, H. Y.; Ingber, D. E. Reconstituting organ-level lung functions on a chip Science 2010, 328, 1662-1668
11. Huh, D.; Leslie, D. C.; Matthews, B. D.; Fraser, J. P.; Jurek, S.; Hamilton, G. A.; Thornelowe, K. S.; McAlexander, M. A.; Ingber, D. E. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice Sci. Transl. Med. 2012, 4, 159ra47
12. Gil, J. W.; Weibel, E. R. Extracellular lining of bronchioles after perfusion-fixation of rat lungs for electron microscopy Anat. Rec. 1971, 169, 185-199
13. Schürch, S.; Gehr, P.; Im Hof, V.; Geiser, M.; Green, F. Surfactant displaces particles toward the epithelium in airways and alveoli Respir. Physiol. 1990, 80, 17-32
14. Schleh, C.; Kreyling, W. G.; Lehr, C.-M. Pulmonary surfactant is indispensable in order to simulate the in vivo situation Part. Fibre Toxicol. 2013, 10
15. Schürch, S.; Bachofen, H.; Goerke, J.; Possmayer, F. A captive bubble method reproduces the in situ behavior of lung surfactant monolayers J. Appl. Physiol. 1989, 67, 2389-2396
16. Schoel, W. M.; Schürch, S.; Goerke, J. The captive bubble method for the evaluation of pulmonary surfactant: surface tension, area, and volume calculations Biochim. Biophy. Acta. 1994, 1200, 281-290
17. Schürch, S.; Goerke, J.; Clements, J. A. Direct determination of surface tension in the lung Proc. Natl. Acad. Sci. U. S. A. 1976, 73, 4698-4702
18. Bachofen, H.; Schürch, S.; Urbinelli, M.; Weibel, E. R. Relations among alveolar surface tension, surface area, volume, and recoil pressure J. Appl. Physiol. 1987, 62, 1878-1887
19. Lieber, M.; Todaro, G.; Smith, B.; Szakal, A.; Nelson-Rees, W. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells Int. J. Cancer 1976, 17, 62-70
20. Blank, F.; Rothen-Rutishauser, B. M.; Schürch, S.; Gehr, P. An optimized in vitro model of the respiratory tract wall to study particle cell interactions J. Aerosol Med. 2006, 19, 392-405
21. Shukla, R.; Bansal, V.; Chaudhary, M.; Basu, A.; Bhonde, R. R. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview Langmuir 2005, 21, 10644-10654
22. Lin, C. A. J.; Sperling, R. A.; Li, J. K.; Yang, T. Y.; Li, P. Y.; Zanella, M.; Chang, W. H.; Parak, W. J. Design of an amphiphilic polymer for nanoparticle coating and functionalization Small 2008, 4, 334-341
23. Mahmoudi, M.; Abdelmonem, A. M.; Behzadi, S.; Clement, J. H.; Dutz, S.; Ejtehadi, M. R.; Hartmann, R.; Kantner, K.; Linne, U.; Maffre, P.; Metzler, S.; Moghadam, M. K.; Pfeiffer, C.; Rezaei, M.; Ruiz-Lozano, P.; Serpooshan, V.; Shokrgozar, M. A.; Nienhaus, G. U.; Parak, W. J. Temperature: the "ignored" factor at the NanoBio interface ACS Nano 2013, 7, 6555-6562
24. Rothen-Rutishauser, B.; Kuhn, D. A.; Ali, Z.; Gasser, M.; Amin, F.; Parak, W. J.; Vanhecke, D.; Fink, A.; Gehr, P.; Brandenberger, C. Quantification of gold nanoparticle cell uptake under controlled biological conditions and adequate resolution. Nanomedicine 2013, in press
25. Schürch, S.; Bachofen, H.; Possmayer, F. Surface activity in situ, in vivo, and in the captive bubble surfactometer Comp. Biochem. Physiol., Part A: Mol. Integr. Physiol. 2001, 129, 195-207
26. Schürch, S.; Green, F. H.; Bachofen, H. Formation and structure of surface films: captive bubble surfactometry Biochim. Biophys. Acta 1998, 1408, 180-202
27. Schürch, D.; Ospina, O. L.; Cruz, A.; Perez-Gil, J. Combined and independent action of proteins SP-B and SP-C in the surface behavior and mechanical stability of pulmonary surfactant films Biophys. J. 2010, 99, 3290-3299
28. Muñoz, J. L. Study of surfactant secretion in the A549 cell line: A tissue culture model for the type II pneumocyte, Yale University, 1978.
29. Bouzas, V.; Haller, T.; Hobi, N.; Felder, E.; Pastoriza-Santos, I.; Perez-Gil, J. Nontoxic impact of PEG-coated gold nanospheres on functional pulmonary surfactant-secreting alveolar type II cells Nanotoxicology 2014, 8, 813-823
30. Bachofen, H.; Schürch, S. Alveolar surface forces and lung architecture Comp. Biochem. Physiol., Part A: Mol. Integr. Physiol. 2001, 129, 183-93
31. Ravasio, A.; Hobi, N.; Bertocchi, C.; Jesacher, A.; Dietl, P.; Haller, T. Interfacial sensing by alveolar type II cells: a new concept in lung physiology? Am. J. Physiol. Cell Physiol. 2011, 300, 456-465
32. Hobi, N.; Ravasio, A.; Haller, T. Interfacial stress affects rat alveolar type II cell signaling and gene expression Am. J. Physiol. Lung Cell Mol. Physiol. 2012, 303, 117-129